Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Erika Guerrero, P. Vasudevaraju, Muralidhar Hegde, G. B. Britton, K. S. Rao

Research output: Contribution to journalReview articlepeer-review

59 Scopus citations

Abstract

The toxicity of α-synuclein in the neuropathology of Parkinson's disease which includes its hallmark aggregation has been studied scrupulously in the last decade. Although little is known regarding the normal functions of α-synuclein, its association with membrane phospholipids suggests its potential role in signaling pathways. Following extensive evidences for its nuclear localization, we and others recently demonstrated DNA binding activity of α-synuclein that modulates its conformation as well as aggregation properties. Furthermore, we also underscored the similarities among various amyloidogenic proteins involved in neurodegenerative diseases including amyloid beta peptides and tau. Our more recent studies show that α-synuclein is glycated and glycosylated both in vitro and in neurons, significantly affecting its folding, oligomeric, and DNA binding properties. Glycated α-synuclein causes increased genome damage both via its direct interaction with DNA and by increased generation of reactive oxygen species as glycation byproduct. In this review, we discuss the mechanisms of glycation and other posttranslational modifications of α-synuclein, including phosphorylation and nitration, and their role in neuronal death in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)525-536
Number of pages12
JournalMolecular Neurobiology
Volume47
Issue number2
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.'. Together they form a unique fingerprint.

Cite this